COVID-19 SeroHub, an online repository of SARS-CoV-2 seroprevalence studies in the United States | Scientific Data

peter.suber's bookmarks 2022-11-27


Abstract:  Seroprevalence studies provide useful information about the proportion of the population either vaccinated against SARS-CoV-2, previously infected with the virus, or both. Numerous studies have been conducted in the United States, but differ substantially by dates of enrollment, target population, geographic location, age distribution, and assays used. This can make it challenging to identify and synthesize available seroprevalence data by geographic region or to compare infection-induced versus combined infection- and vaccination-induced seroprevalence. To facilitate public access and understanding, the National Institutes of Health and the Centers for Disease Control and Prevention developed the COVID-19 Seroprevalence Studies Hub (COVID-19 SeroHub,, a data repository in which seroprevalence studies are systematically identified, extracted using a standard format, and summarized through an interactive interface. Within COVID-19 SeroHub, users can explore and download data from 178 studies as of September 1, 2022. Tools allow users to filter results and visualize trends over time, geography, population, age, and antigen target. Because COVID-19 remains an ongoing pandemic, we will continue to identify and include future studies.



From feeds:

Open Access Tracking Project (OATP) » peter.suber's bookmarks

Tags: oa.medicine oa.repositories oa.usa oa.usa.nih oa.usa.cdc oa.extractions oa.summaries oa.interactivity

Date tagged:

11/27/2022, 15:47

Date published:

11/27/2022, 10:47